  |
|
|
|
Presidio Pay Advisors is pleased to present a series of compensation studies covering Executive and Board of Directors compensation for companies in the Biotech Industry. |
|
2005 -- 2007
|
|
Biotech Executive Compensation
|
2006 Biotech Executive Compensation Survey Synopsis
The Executive Compensation Survey Synopsis is an overview of our findings for executive base salary, actual annual incentive, present value of stock option and other forms of long-term incentives, and beneficial ownership for sixteen (16) executive positions in sixty-seven (67) companies in the Biotech Industry.
|
2006 Biotech Executive Compensation Survey
The Presidio Pay 2006 Executive Compensation Survey for the Biotech Industry includes base salary, actual annual incentive, present value of stock options and other forms of long-term incentives, and beneficial ownership for sixteen (16) executive positions in sixty-seven (67) companies in the Biotech Industry.
PRICE: $650.00
|
|
* * * * * |
|
Biotech Board of Directors Compensation
|
2006 Biotech Board of Directors Compensation Survey Synopsis
The Board of Directors Biotech Survey Synopsis is a free report that presents sample data layout, methodology and terms, a company list, and general company data for those companies included in the 2006 Presidio Pay Biotech Industry Board of Directors Compensation Survey. The full survey is available for purchase below and includes Board and Committee cash and equity compensation data for Chairmen, Lead Directors, and Non-Employee members of the Board of Directors in sixty-nine (69) companies.
|
2006 Biotech Board of Directors Compensation Survey
The 2006 Biotech Board of Directors Compensation Survey has compiled Board and Committee cash and equity compensation data for Non-Employee members of the Board of Directors and Committees of the Board in sixty-nine (69) companies. The survey includes data for Chairmen, Lead Directors, and Directors for both Board service and service on eight (8) different Committees. Data includes: Annual Board Retainer, Per Board Meeting Fees, Committee Annual Retainers, Per Committee Meeting Fees, and Present Value of Election and Ongoing Equity Grants.
PRICE: $650.00
|
|
* * * * * |
|
Biotech Equity Compensation
|
2006 Biotech Equity Compensation Survey Synopsis
The Equity Compensation Survey Synopsis is an overview of our findings for stock option overhang, stock option run-rate, and ownership levels for the CEO, outside Directors, and executive officers and Directors combined in sixty-nine (69) companies in the Biotech Industry.
|
2006 Biotech Equity Compensation Survey
The Equity Compensation Survey presents current year and three-year average stock option overhang and stock option run-rate in sixty-nine (69) companies. The survey also presents ownership levels for CEO, outside Directors, and executive officers and Directors combined. Certain equity compensation plan metrics, including non-shareholder approved stock option plans, evergreen plans, and proxy statement additional share requests are also included. Finally, this survey provides summary information on stock option expensing and strategies for using restricted stock as opposed to stock options.
PRICE: $650.00
|
|
* * * * * |
|
